Pediatrix Medical Group Inc Asset Turnover Ratio (MD), as of second quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Pediatrix Medical Group Inc   (NYSE: MD)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 

Pediatrix Medical Group Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Pediatrix Medical Group Inc 's asset turnover ratio has remained unchanged compare to previous quarter at 0.9 in the second quarter (Jun 30 2026)

Within sector 20 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the II Quarter 2026, to 1082, from total ranking in the first quarter 2026 at 1226.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

MD Asset Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Asset Change 1.34 % 3.85 % 11.63 % 15.6 % 16.31 %
Y / Y Revenue Change 4.04 % 3.89 % -1.71 % -3.58 % -7.03 %
Asset Turnover Ratio (TTM) 0.9 0.9 0.9 0.93 0.97
MD's Total Ranking # 1082 # 1226 # 1388 # 1472 # 924
Seq. Asset Change 2.9 % -7.85 % 2.15 % 4.63 % 5.45 %
Seq. Revenue Change 2.43 % -3.56 % 0.18 % 5.13 % 2.29 %



Asset Turnover Ratio Company Ranking
Within: No.
Healthcare Facilities Industry # 21
Healthcare Sector # 135
Overall Market # 1082

Asset Turnover Ratio Statistics
High Average Low
0.99 0.75 0.42
(Sep 30 2019)   (Mar 31 2021)




MD Company Profile • Back to MD Efficiency Comparisons • Compare MD Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Assets at quarter ending Jun 30 2026
P3 Health Partners Inc   2.25 $ 1,502.838  Millions$ 667.189  Millions
Vycor Medical Inc   2.10 $ 1.807  Millions$ 0.860  Millions
Iridex Corp  1.81 $ 51.044  Millions$ 28.259  Millions
Progyny Inc   1.78 $ 1,311.298  Millions$ 737.959  Millions
Chemed Corporation  1.65 $ 2,595.001  Millions$ 1,569.302  Millions
Aspira Women s Health inc   1.62 $ 9.029  Millions$ 5.569  Millions
Adm Tronics Unlimited Inc   1.59 $ 3.240  Millions$ 2.034  Millions
Lftd Partners Inc   1.56 $ 35.335  Millions$ 22.674  Millions
Nephros Inc   1.54 $ 21.686  Millions$ 14.113  Millions
Medinotec Inc   1.52 $ 10.247  Millions$ 6.745  Millions
Evofem Biosciences Inc   1.47 $ 18.045  Millions$ 12.261  Millions
Infusystem Holdings Inc  1.45 $ 143.335  Millions$ 98.950  Millions
Medpace Holdings Inc   1.41 $ 2,782.288  Millions$ 1,978.819  Millions
Edap Tms Sa  1.37 $ 111.051  Millions$ 81.022  Millions
Idexx Laboratories Inc  1.34 $ 4,553.792  Millions$ 3,391.326  Millions
Vaxart Inc   1.31 $ 243.064  Millions$ 185.077  Millions
Lifeloc Technologies Inc   1.29 $ 9.269  Millions$ 7.201  Millions
Precipio inc   1.29 $ 27.198  Millions$ 21.149  Millions
Interpace Biosciences Inc   1.28 $ 36.519  Millions$ 28.458  Millions
Electromed Inc   1.24 $ 72.076  Millions$ 58.289  Millions
Ardent Health Inc   1.22 $ 6,405.940  Millions$ 5,244.371  Millions
Docgo Inc   1.22 $ 294.721  Millions$ 241.732  Millions
Henry Schein Inc   1.21 $ 13,602.000  Millions$ 11,249.250  Millions
Inogen Inc   1.20 $ 354.304  Millions$ 294.283  Millions
Universal Health Services Inc   1.19 $ 18,646.705  Millions$ 15,622.036  Millions
Angiodynamics Inc   1.18 $ 317.726  Millions$ 268.407  Millions
Myriad Genetics Inc   1.17 $ 805.900  Millions$ 686.825  Millions
Polomar Health Services, Inc.  1.15 $ 3.172  Millions$ 2.748  Millions
Natera Inc   1.14 $ 2,707.077  Millions$ 2,372.930  Millions
Elite Pharmaceuticals Inc   1.14 $ 140.130  Millions$ 122.899  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.